In addition to C1‐INH treatment, patients reported using increased dose of danazol (7/57 patients [12.3%]), icatibant (17/57 patients [29.8%]), and FFP (2/57 patients [3.5%]) for the treatment of HAE attacks. This evidence concerns the gene SERPING1 and hereditary angioedema.